UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Factors influencing institutionalization of health technology assessment in Kenya

BMC health services research, 2023-06, Vol.23 (1), p.681-681, Article 681

2023

Link zum Volltext

Verfügbarkeit prüfen

Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature

BMC public health, 2023-05, Vol.23 (1), p.1003-1003

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of COVID-19 restrictive measures on income and health service utilization of tuberculosis patients in India

BMC infectious diseases, 2022-08, Vol.22 (1), p.711-711, Article 711

2022

Link zum Volltext

Verfügbarkeit prüfen

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

PLoS medicine, 2013-03, Vol.10 (3), p.e1001401

2013

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive framework for considering additional unintended consequences in economic evaluation

Cost effectiveness and resource allocation, 2020-08, Vol.18 (1), p.27-27, Article 27

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

Proceedings of the National Academy of Sciences - PNAS, 2014-10, Vol.111 (43), p.15520-15525

2014

Link zum Volltext

Verfügbarkeit prüfen

Count the cost of disability caused by COVID-19

Nature (London), 2021-05, Vol.593 (7860), p.502-505

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective

Value in health, 2017-04, Vol.20 (4), p.699-704

2017

Link zum Volltext

Verfügbarkeit prüfen

Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines

PloS one, 2024-01, Vol.19 (1), p.e0297342-e0297342

2024

Link zum Volltext

Verfügbarkeit prüfen

Financing intersectoral action for health: a systematic review of co-financing models

Globalization and health, 2019-12, Vol.15 (1), p.86-86, Article 86

2019

Link zum Volltext

Verfügbarkeit prüfen

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

PLoS medicine, 2011-11, Vol.8 (11), p.e1001120-e1001120

2011

Link zum Volltext

Verfügbarkeit prüfen

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review

BMC medicine, 2021-12, Vol.19 (1), p.318-318, Article 318

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

The Lancet global health, 2017-07, Vol.5 (7), p.e710-e719

2017

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

PLoS medicine, 2021-10, Vol.18 (10), p.e1003815-e1003815

2021

Link zum Volltext

Verfügbarkeit prüfen

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model

BMC medicine, 2019-08, Vol.17 (1), p.155-155, Article 155

2019

Link zum Volltext

Verfügbarkeit prüfen

Is there a role for RDTs as we live with COVID-19? An assessment of different strategies

BMJ global health, 2023-01, Vol.8 (1), p.e010690

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

BMJ open, 2021-12, Vol.11 (12), p.e051521-e051521

2021

Link zum Volltext

Verfügbarkeit prüfen

Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries

Bulletin of the World Health Organization, 2014-07, Vol.92 (7), p.499-511

2014

Link zum Volltext

Verfügbarkeit prüfen

"We usually see a lot of delay in terms of coming for or seeking care": an expert consultation on COVID testing and care pathways in seven low- and middle-income countries

BMC health services research, 2023-11, Vol.23 (1), p.1288-1288, Article 1288

2023

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

The Lancet global health, 2016-11, Vol.4 (11), p.e806-e815

2016

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey

BMC infectious diseases, 2023-05, Vol.23 (1), p.321-321, Article 321

2023

Link zum Volltext

Verfügbarkeit prüfen

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis

PloS one, 2013-12, Vol.8 (12), p.e82786-e82786

2013

Link zum Volltext

Verfügbarkeit prüfen

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa

PloS one, 2019-12, Vol.14 (12), p.e0225742-e0225742

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction: Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

Trials, 2024-03, Vol.25 (1), p.208-208

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries

BMC medicine, 2023-03, Vol.21 (1), p.85-85, Article 85

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(144)
Life Sciences & Biomedicine
(120)
Humans
(118)
Hiv
(57)
Human Immunodeficiency Virus
(52)
Tuberculosis
(50)
Public Health
(46)
Cost Analysis
(42)
Health Care Sciences & Services
(41)
Public, Environmental & Occupational Health
(41)
Female
(39)
Cost-Benefit Analysis
(38)
Health Policy & Services
(36)
Male
(36)
Social Sciences
(36)
Infectious Diseases
(30)
Adult
(29)
Economic Aspects
(28)
Medicine
(28)
Costs
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Factors influencing institutionalization of health technology assessment in Kenya

Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature

Impact of COVID-19 restrictive measures on income and health service utilization of tuberculosis patients in India

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

A comprehensive framework for considering additional unintended consequences in economic evaluation

Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries

Count the cost of disability caused by COVID-19

Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective

Costs incurred by people with co-morbid tuberculosis and diabetes and their households in the Philippines

Financing intersectoral action for health: a systematic review of co-financing models

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review

Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model

Is there a role for RDTs as we live with COVID-19? An assessment of different strategies

Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines

Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries

"We usually see a lot of delay in terms of coming for or seeking care": an expert consultation on COVID testing and care pathways in seven low- and middle-income countries

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models

COVID-19 vaccine hesitancy and social contact patterns in Pakistan: results from a national cross-sectional survey

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis

Pathways to care and outcomes among hospitalised HIV-seropositive persons with cryptococcal meningitis in South Africa

Correction: Effectiveness and cost-effectiveness of a transdiagnostic intervention for alcohol misuse and psychological distress in humanitarian settings: study protocol for a randomised controlled trial in Uganda

Assessing the impacts of COVID-19 vaccination programme's timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries

Suchergebnisse filtern